Global Plant-based Vaccines Market

Plant-based Vaccines Comprehensive Study by Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Immunocontraceptive Vaccines), Application (Infectious Diseases, Anti-Cancer, Covid19, Others), Plant (Tobacco, Potatoes, Tomato, Others), End Users (Hospitals, Specialized Clinics) Players and Region - Global Market Outlook to 2028

Plant-based Vaccines Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Plant-based vaccines are made using recombinant technology, which involves integrating the gene encoding the required antigen protein into the plant genome. For gene transfer and transformation, the Agrobacterium tumefaciens is often utilized. Novel methods for transformation, including sonication, biolistic bombardment, PEG-mediated, and electroporation, are being used as technology advances.This growth is primarily driven by Plant-Based Vaccines are Produced on a Large Scale and are Cost-Effective .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitK Tons
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Biotechnology sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Medicago (Canada), GlaxoSmithKline (United Kingdom), Creative Biolabs (United States), iBio (United States), Fraunhofer (Germany), ICON (Ireland), Mitsubishi Tanabe (Japan), Protalix (Israel) and Kentucky Bioprocessing, Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In March 2021 Medicago Announced the Start of Clinical Trails of Plant-Based Covid-19 Vaccine Patient with help of GSK Pandemic Antidote. The COVID-19 vaccine candidate developed by Medicago is based on plant extracts. The vaccine is made up of recombinant spike (S) glycoprotein produced as virus-like particles (VLPs) and is co-administered with GSK's pandemic antidote. Based on excellent interim Phase 2 results, Medicago gained regulatory approval from Canadian and US authorities to begin enrolling healthy individuals in the Phase 3 part of the trial.The demand for Plant-based Vaccines is increasing due to large vaccine production at cost-effective prices. The businesses in this industry facing major competition on a global scale with leading players of the market who hold a major market share. The Leading Players are engaged in organic and non-organic strategic global expansion to maintain their Market Position.

Influencing Trend:
Plant-Based Vaccines are Used for Coivid19 Treatment

Market Growth Drivers:
Plant-Based Vaccines are Produced on a Large Scale and are Cost-Effective and Rapid Development in Treatment of Cancer

Challenges:
Identifying an Antigen and an Appropriate Plant Development Host and Different Individuals' Adaptive Immune Responses Can Fluctuate

Restraints:
The Consistency of Vaccine Differs bases on the Type and Size of the Plants

Opportunities:
Rapid Diagnostics of Infectious Diseases and Increase in Cases of Influenza

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Plant-based Vaccines Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Plant-based Vaccines Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Plant-based Vaccines players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Plant-based Vaccines Study Sheds Light on
— The Plant-based Vaccines Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Plant-based Vaccines industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Plant-based Vaccines industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Bacterial Vaccines
  • Viral Vaccines
  • Parasite Vaccines
  • Immunocontraceptive Vaccines
By Application
  • Infectious Diseases
  • Anti-Cancer
  • Covid19
  • Others
By Plant
  • Tobacco
  • Potatoes
  • Tomato
  • Others

By End Users
  • Hospitals
  • Specialized Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Plant-Based Vaccines are Produced on a Large Scale and are Cost-Effective
      • 3.2.2. Rapid Development in Treatment of Cancer
    • 3.3. Market Challenges
      • 3.3.1. Identifying an Antigen and an Appropriate Plant Development Host
      • 3.3.2. Different Individuals' Adaptive Immune Responses Can Fluctuate
    • 3.4. Market Trends
      • 3.4.1. Plant-Based Vaccines are Used for Coivid19 Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Plant-based Vaccines, by Type, Application, Plant, End Users and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Plant-based Vaccines (Value)
      • 5.2.1. Global Plant-based Vaccines by: Type (Value)
        • 5.2.1.1. Bacterial Vaccines
        • 5.2.1.2. Viral Vaccines
        • 5.2.1.3. Parasite Vaccines
        • 5.2.1.4. Immunocontraceptive Vaccines
      • 5.2.2. Global Plant-based Vaccines by: Application (Value)
        • 5.2.2.1. Infectious Diseases
        • 5.2.2.2. Anti-Cancer
        • 5.2.2.3. Covid19
        • 5.2.2.4. Others
      • 5.2.3. Global Plant-based Vaccines by: Plant (Value)
        • 5.2.3.1. Tobacco
        • 5.2.3.2. Potatoes
        • 5.2.3.3. Tomato
        • 5.2.3.4. Others
      • 5.2.4. Global Plant-based Vaccines by: End Users (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Specialized Clinics
      • 5.2.5. Global Plant-based Vaccines Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Plant-based Vaccines (Volume)
      • 5.3.1. Global Plant-based Vaccines by: Type (Volume)
        • 5.3.1.1. Bacterial Vaccines
        • 5.3.1.2. Viral Vaccines
        • 5.3.1.3. Parasite Vaccines
        • 5.3.1.4. Immunocontraceptive Vaccines
      • 5.3.2. Global Plant-based Vaccines by: Application (Volume)
        • 5.3.2.1. Infectious Diseases
        • 5.3.2.2. Anti-Cancer
        • 5.3.2.3. Covid19
        • 5.3.2.4. Others
      • 5.3.3. Global Plant-based Vaccines by: Plant (Volume)
        • 5.3.3.1. Tobacco
        • 5.3.3.2. Potatoes
        • 5.3.3.3. Tomato
        • 5.3.3.4. Others
      • 5.3.4. Global Plant-based Vaccines by: End Users (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Specialized Clinics
      • 5.3.5. Global Plant-based Vaccines Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Plant-based Vaccines (Price)
      • 5.4.1. Global Plant-based Vaccines by: Type (Price)
  • 6. Plant-based Vaccines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medicago (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Creative Biolabs (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. IBio (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fraunhofer (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ICON (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mitsubishi Tanabe (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Protalix (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Kentucky Bioprocessing, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Plant-based Vaccines Sale, by Type, Application, Plant, End Users and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Plant-based Vaccines (Value)
      • 7.2.1. Global Plant-based Vaccines by: Type (Value)
        • 7.2.1.1. Bacterial Vaccines
        • 7.2.1.2. Viral Vaccines
        • 7.2.1.3. Parasite Vaccines
        • 7.2.1.4. Immunocontraceptive Vaccines
      • 7.2.2. Global Plant-based Vaccines by: Application (Value)
        • 7.2.2.1. Infectious Diseases
        • 7.2.2.2. Anti-Cancer
        • 7.2.2.3. Covid19
        • 7.2.2.4. Others
      • 7.2.3. Global Plant-based Vaccines by: Plant (Value)
        • 7.2.3.1. Tobacco
        • 7.2.3.2. Potatoes
        • 7.2.3.3. Tomato
        • 7.2.3.4. Others
      • 7.2.4. Global Plant-based Vaccines by: End Users (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Specialized Clinics
      • 7.2.5. Global Plant-based Vaccines Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Plant-based Vaccines (Volume)
      • 7.3.1. Global Plant-based Vaccines by: Type (Volume)
        • 7.3.1.1. Bacterial Vaccines
        • 7.3.1.2. Viral Vaccines
        • 7.3.1.3. Parasite Vaccines
        • 7.3.1.4. Immunocontraceptive Vaccines
      • 7.3.2. Global Plant-based Vaccines by: Application (Volume)
        • 7.3.2.1. Infectious Diseases
        • 7.3.2.2. Anti-Cancer
        • 7.3.2.3. Covid19
        • 7.3.2.4. Others
      • 7.3.3. Global Plant-based Vaccines by: Plant (Volume)
        • 7.3.3.1. Tobacco
        • 7.3.3.2. Potatoes
        • 7.3.3.3. Tomato
        • 7.3.3.4. Others
      • 7.3.4. Global Plant-based Vaccines by: End Users (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Specialized Clinics
      • 7.3.5. Global Plant-based Vaccines Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Plant-based Vaccines (Price)
      • 7.4.1. Global Plant-based Vaccines by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Plant-based Vaccines: by Type(USD Million)
  • Table 2. Plant-based Vaccines Bacterial Vaccines , by Region USD Million (2017-2022)
  • Table 3. Plant-based Vaccines Viral Vaccines , by Region USD Million (2017-2022)
  • Table 4. Plant-based Vaccines Parasite Vaccines , by Region USD Million (2017-2022)
  • Table 5. Plant-based Vaccines Immunocontraceptive Vaccines , by Region USD Million (2017-2022)
  • Table 6. Plant-based Vaccines: by Application(USD Million)
  • Table 7. Plant-based Vaccines Infectious Diseases , by Region USD Million (2017-2022)
  • Table 8. Plant-based Vaccines Anti-Cancer , by Region USD Million (2017-2022)
  • Table 9. Plant-based Vaccines Covid19 , by Region USD Million (2017-2022)
  • Table 10. Plant-based Vaccines Others , by Region USD Million (2017-2022)
  • Table 11. Plant-based Vaccines: by Plant(USD Million)
  • Table 12. Plant-based Vaccines Tobacco , by Region USD Million (2017-2022)
  • Table 13. Plant-based Vaccines Potatoes , by Region USD Million (2017-2022)
  • Table 14. Plant-based Vaccines Tomato , by Region USD Million (2017-2022)
  • Table 15. Plant-based Vaccines Others , by Region USD Million (2017-2022)
  • Table 16. Plant-based Vaccines: by End Users(USD Million)
  • Table 17. Plant-based Vaccines Hospitals , by Region USD Million (2017-2022)
  • Table 18. Plant-based Vaccines Specialized Clinics , by Region USD Million (2017-2022)
  • Table 19. South America Plant-based Vaccines, by Country USD Million (2017-2022)
  • Table 20. South America Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 21. South America Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 22. South America Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 23. South America Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 24. Brazil Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 25. Brazil Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 26. Brazil Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 27. Brazil Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 28. Argentina Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 29. Argentina Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 30. Argentina Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 31. Argentina Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 32. Rest of South America Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 33. Rest of South America Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 34. Rest of South America Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 35. Rest of South America Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 36. Asia Pacific Plant-based Vaccines, by Country USD Million (2017-2022)
  • Table 37. Asia Pacific Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 38. Asia Pacific Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 39. Asia Pacific Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 40. Asia Pacific Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 41. China Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 42. China Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 43. China Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 44. China Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 45. Japan Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 46. Japan Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 47. Japan Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 48. Japan Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 49. India Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 50. India Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 51. India Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 52. India Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 53. South Korea Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 54. South Korea Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 55. South Korea Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 56. South Korea Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 57. Taiwan Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 58. Taiwan Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 59. Taiwan Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 60. Taiwan Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 61. Australia Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 62. Australia Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 63. Australia Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 64. Australia Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 69. Europe Plant-based Vaccines, by Country USD Million (2017-2022)
  • Table 70. Europe Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 71. Europe Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 72. Europe Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 73. Europe Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 74. Germany Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 75. Germany Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 76. Germany Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 77. Germany Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 78. France Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 79. France Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 80. France Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 81. France Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 82. Italy Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 83. Italy Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 84. Italy Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 85. Italy Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 86. United Kingdom Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 87. United Kingdom Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 88. United Kingdom Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 89. United Kingdom Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 90. Netherlands Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 91. Netherlands Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 92. Netherlands Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 93. Netherlands Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 94. Rest of Europe Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 95. Rest of Europe Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 96. Rest of Europe Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 97. Rest of Europe Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 98. MEA Plant-based Vaccines, by Country USD Million (2017-2022)
  • Table 99. MEA Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 100. MEA Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 101. MEA Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 102. MEA Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 103. Middle East Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 104. Middle East Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 105. Middle East Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 106. Middle East Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 107. Africa Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 108. Africa Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 109. Africa Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 110. Africa Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 111. North America Plant-based Vaccines, by Country USD Million (2017-2022)
  • Table 112. North America Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 113. North America Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 114. North America Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 115. North America Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 116. United States Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 117. United States Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 118. United States Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 119. United States Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 120. Canada Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 121. Canada Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 122. Canada Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 123. Canada Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 124. Mexico Plant-based Vaccines, by Type USD Million (2017-2022)
  • Table 125. Mexico Plant-based Vaccines, by Application USD Million (2017-2022)
  • Table 126. Mexico Plant-based Vaccines, by Plant USD Million (2017-2022)
  • Table 127. Mexico Plant-based Vaccines, by End Users USD Million (2017-2022)
  • Table 128. Plant-based Vaccines Sales: by Type(K Tons)
  • Table 129. Plant-based Vaccines Sales Bacterial Vaccines , by Region K Tons (2017-2022)
  • Table 130. Plant-based Vaccines Sales Viral Vaccines , by Region K Tons (2017-2022)
  • Table 131. Plant-based Vaccines Sales Parasite Vaccines , by Region K Tons (2017-2022)
  • Table 132. Plant-based Vaccines Sales Immunocontraceptive Vaccines , by Region K Tons (2017-2022)
  • Table 133. Plant-based Vaccines Sales: by Application(K Tons)
  • Table 134. Plant-based Vaccines Sales Infectious Diseases , by Region K Tons (2017-2022)
  • Table 135. Plant-based Vaccines Sales Anti-Cancer , by Region K Tons (2017-2022)
  • Table 136. Plant-based Vaccines Sales Covid19 , by Region K Tons (2017-2022)
  • Table 137. Plant-based Vaccines Sales Others , by Region K Tons (2017-2022)
  • Table 138. Plant-based Vaccines Sales: by Plant(K Tons)
  • Table 139. Plant-based Vaccines Sales Tobacco , by Region K Tons (2017-2022)
  • Table 140. Plant-based Vaccines Sales Potatoes , by Region K Tons (2017-2022)
  • Table 141. Plant-based Vaccines Sales Tomato , by Region K Tons (2017-2022)
  • Table 142. Plant-based Vaccines Sales Others , by Region K Tons (2017-2022)
  • Table 143. Plant-based Vaccines Sales: by End Users(K Tons)
  • Table 144. Plant-based Vaccines Sales Hospitals , by Region K Tons (2017-2022)
  • Table 145. Plant-based Vaccines Sales Specialized Clinics , by Region K Tons (2017-2022)
  • Table 146. South America Plant-based Vaccines Sales, by Country K Tons (2017-2022)
  • Table 147. South America Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 148. South America Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 149. South America Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 150. South America Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 151. Brazil Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 152. Brazil Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 153. Brazil Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 154. Brazil Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 155. Argentina Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 156. Argentina Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 157. Argentina Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 158. Argentina Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 159. Rest of South America Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 160. Rest of South America Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 161. Rest of South America Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 162. Rest of South America Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 163. Asia Pacific Plant-based Vaccines Sales, by Country K Tons (2017-2022)
  • Table 164. Asia Pacific Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 165. Asia Pacific Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 166. Asia Pacific Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 167. Asia Pacific Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 168. China Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 169. China Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 170. China Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 171. China Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 172. Japan Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 173. Japan Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 174. Japan Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 175. Japan Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 176. India Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 177. India Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 178. India Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 179. India Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 180. South Korea Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 181. South Korea Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 182. South Korea Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 183. South Korea Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 184. Taiwan Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 185. Taiwan Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 186. Taiwan Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 187. Taiwan Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 188. Australia Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 189. Australia Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 190. Australia Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 191. Australia Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 192. Rest of Asia-Pacific Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 193. Rest of Asia-Pacific Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 194. Rest of Asia-Pacific Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 195. Rest of Asia-Pacific Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 196. Europe Plant-based Vaccines Sales, by Country K Tons (2017-2022)
  • Table 197. Europe Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 198. Europe Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 199. Europe Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 200. Europe Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 201. Germany Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 202. Germany Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 203. Germany Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 204. Germany Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 205. France Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 206. France Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 207. France Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 208. France Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 209. Italy Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 210. Italy Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 211. Italy Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 212. Italy Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 213. United Kingdom Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 214. United Kingdom Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 215. United Kingdom Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 216. United Kingdom Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 217. Netherlands Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 218. Netherlands Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 219. Netherlands Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 220. Netherlands Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 221. Rest of Europe Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 222. Rest of Europe Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 223. Rest of Europe Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 224. Rest of Europe Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 225. MEA Plant-based Vaccines Sales, by Country K Tons (2017-2022)
  • Table 226. MEA Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 227. MEA Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 228. MEA Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 229. MEA Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 230. Middle East Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 231. Middle East Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 232. Middle East Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 233. Middle East Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 234. Africa Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 235. Africa Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 236. Africa Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 237. Africa Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 238. North America Plant-based Vaccines Sales, by Country K Tons (2017-2022)
  • Table 239. North America Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 240. North America Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 241. North America Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 242. North America Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 243. United States Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 244. United States Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 245. United States Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 246. United States Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 247. Canada Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 248. Canada Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 249. Canada Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 250. Canada Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 251. Mexico Plant-based Vaccines Sales, by Type K Tons (2017-2022)
  • Table 252. Mexico Plant-based Vaccines Sales, by Application K Tons (2017-2022)
  • Table 253. Mexico Plant-based Vaccines Sales, by Plant K Tons (2017-2022)
  • Table 254. Mexico Plant-based Vaccines Sales, by End Users K Tons (2017-2022)
  • Table 255. Plant-based Vaccines: by Type(USD/Units)
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Plant-based Vaccines: by Type(USD Million)
  • Table 266. Plant-based Vaccines Bacterial Vaccines , by Region USD Million (2023-2028)
  • Table 267. Plant-based Vaccines Viral Vaccines , by Region USD Million (2023-2028)
  • Table 268. Plant-based Vaccines Parasite Vaccines , by Region USD Million (2023-2028)
  • Table 269. Plant-based Vaccines Immunocontraceptive Vaccines , by Region USD Million (2023-2028)
  • Table 270. Plant-based Vaccines: by Application(USD Million)
  • Table 271. Plant-based Vaccines Infectious Diseases , by Region USD Million (2023-2028)
  • Table 272. Plant-based Vaccines Anti-Cancer , by Region USD Million (2023-2028)
  • Table 273. Plant-based Vaccines Covid19 , by Region USD Million (2023-2028)
  • Table 274. Plant-based Vaccines Others , by Region USD Million (2023-2028)
  • Table 275. Plant-based Vaccines: by Plant(USD Million)
  • Table 276. Plant-based Vaccines Tobacco , by Region USD Million (2023-2028)
  • Table 277. Plant-based Vaccines Potatoes , by Region USD Million (2023-2028)
  • Table 278. Plant-based Vaccines Tomato , by Region USD Million (2023-2028)
  • Table 279. Plant-based Vaccines Others , by Region USD Million (2023-2028)
  • Table 280. Plant-based Vaccines: by End Users(USD Million)
  • Table 281. Plant-based Vaccines Hospitals , by Region USD Million (2023-2028)
  • Table 282. Plant-based Vaccines Specialized Clinics , by Region USD Million (2023-2028)
  • Table 283. South America Plant-based Vaccines, by Country USD Million (2023-2028)
  • Table 284. South America Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 285. South America Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 286. South America Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 287. South America Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 288. Brazil Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 289. Brazil Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 290. Brazil Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 291. Brazil Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 292. Argentina Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 293. Argentina Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 294. Argentina Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 295. Argentina Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 296. Rest of South America Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 297. Rest of South America Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 298. Rest of South America Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 299. Rest of South America Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 300. Asia Pacific Plant-based Vaccines, by Country USD Million (2023-2028)
  • Table 301. Asia Pacific Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 302. Asia Pacific Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 303. Asia Pacific Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 304. Asia Pacific Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 305. China Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 306. China Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 307. China Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 308. China Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 309. Japan Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 310. Japan Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 311. Japan Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 312. Japan Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 313. India Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 314. India Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 315. India Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 316. India Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 317. South Korea Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 318. South Korea Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 319. South Korea Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 320. South Korea Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 321. Taiwan Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 322. Taiwan Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 323. Taiwan Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 324. Taiwan Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 325. Australia Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 326. Australia Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 327. Australia Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 328. Australia Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 329. Rest of Asia-Pacific Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 330. Rest of Asia-Pacific Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 331. Rest of Asia-Pacific Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 332. Rest of Asia-Pacific Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 333. Europe Plant-based Vaccines, by Country USD Million (2023-2028)
  • Table 334. Europe Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 335. Europe Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 336. Europe Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 337. Europe Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 338. Germany Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 339. Germany Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 340. Germany Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 341. Germany Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 342. France Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 343. France Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 344. France Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 345. France Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 346. Italy Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 347. Italy Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 348. Italy Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 349. Italy Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 350. United Kingdom Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 351. United Kingdom Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 352. United Kingdom Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 353. United Kingdom Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 354. Netherlands Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 355. Netherlands Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 356. Netherlands Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 357. Netherlands Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 358. Rest of Europe Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 359. Rest of Europe Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 360. Rest of Europe Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 361. Rest of Europe Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 362. MEA Plant-based Vaccines, by Country USD Million (2023-2028)
  • Table 363. MEA Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 364. MEA Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 365. MEA Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 366. MEA Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 367. Middle East Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 368. Middle East Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 369. Middle East Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 370. Middle East Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 371. Africa Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 372. Africa Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 373. Africa Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 374. Africa Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 375. North America Plant-based Vaccines, by Country USD Million (2023-2028)
  • Table 376. North America Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 377. North America Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 378. North America Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 379. North America Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 380. United States Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 381. United States Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 382. United States Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 383. United States Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 384. Canada Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 385. Canada Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 386. Canada Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 387. Canada Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 388. Mexico Plant-based Vaccines, by Type USD Million (2023-2028)
  • Table 389. Mexico Plant-based Vaccines, by Application USD Million (2023-2028)
  • Table 390. Mexico Plant-based Vaccines, by Plant USD Million (2023-2028)
  • Table 391. Mexico Plant-based Vaccines, by End Users USD Million (2023-2028)
  • Table 392. Plant-based Vaccines Sales: by Type(K Tons)
  • Table 393. Plant-based Vaccines Sales Bacterial Vaccines , by Region K Tons (2023-2028)
  • Table 394. Plant-based Vaccines Sales Viral Vaccines , by Region K Tons (2023-2028)
  • Table 395. Plant-based Vaccines Sales Parasite Vaccines , by Region K Tons (2023-2028)
  • Table 396. Plant-based Vaccines Sales Immunocontraceptive Vaccines , by Region K Tons (2023-2028)
  • Table 397. Plant-based Vaccines Sales: by Application(K Tons)
  • Table 398. Plant-based Vaccines Sales Infectious Diseases , by Region K Tons (2023-2028)
  • Table 399. Plant-based Vaccines Sales Anti-Cancer , by Region K Tons (2023-2028)
  • Table 400. Plant-based Vaccines Sales Covid19 , by Region K Tons (2023-2028)
  • Table 401. Plant-based Vaccines Sales Others , by Region K Tons (2023-2028)
  • Table 402. Plant-based Vaccines Sales: by Plant(K Tons)
  • Table 403. Plant-based Vaccines Sales Tobacco , by Region K Tons (2023-2028)
  • Table 404. Plant-based Vaccines Sales Potatoes , by Region K Tons (2023-2028)
  • Table 405. Plant-based Vaccines Sales Tomato , by Region K Tons (2023-2028)
  • Table 406. Plant-based Vaccines Sales Others , by Region K Tons (2023-2028)
  • Table 407. Plant-based Vaccines Sales: by End Users(K Tons)
  • Table 408. Plant-based Vaccines Sales Hospitals , by Region K Tons (2023-2028)
  • Table 409. Plant-based Vaccines Sales Specialized Clinics , by Region K Tons (2023-2028)
  • Table 410. South America Plant-based Vaccines Sales, by Country K Tons (2023-2028)
  • Table 411. South America Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 412. South America Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 413. South America Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 414. South America Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 415. Brazil Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 416. Brazil Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 417. Brazil Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 418. Brazil Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 419. Argentina Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 420. Argentina Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 421. Argentina Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 422. Argentina Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 423. Rest of South America Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 424. Rest of South America Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 425. Rest of South America Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 426. Rest of South America Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 427. Asia Pacific Plant-based Vaccines Sales, by Country K Tons (2023-2028)
  • Table 428. Asia Pacific Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 429. Asia Pacific Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 430. Asia Pacific Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 431. Asia Pacific Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 432. China Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 433. China Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 434. China Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 435. China Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 436. Japan Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 437. Japan Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 438. Japan Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 439. Japan Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 440. India Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 441. India Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 442. India Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 443. India Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 444. South Korea Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 445. South Korea Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 446. South Korea Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 447. South Korea Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 448. Taiwan Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 449. Taiwan Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 450. Taiwan Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 451. Taiwan Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 452. Australia Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 453. Australia Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 454. Australia Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 455. Australia Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 456. Rest of Asia-Pacific Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 457. Rest of Asia-Pacific Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 458. Rest of Asia-Pacific Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 459. Rest of Asia-Pacific Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 460. Europe Plant-based Vaccines Sales, by Country K Tons (2023-2028)
  • Table 461. Europe Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 462. Europe Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 463. Europe Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 464. Europe Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 465. Germany Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 466. Germany Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 467. Germany Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 468. Germany Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 469. France Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 470. France Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 471. France Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 472. France Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 473. Italy Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 474. Italy Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 475. Italy Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 476. Italy Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 477. United Kingdom Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 478. United Kingdom Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 479. United Kingdom Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 480. United Kingdom Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 481. Netherlands Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 482. Netherlands Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 483. Netherlands Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 484. Netherlands Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 485. Rest of Europe Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 486. Rest of Europe Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 487. Rest of Europe Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 488. Rest of Europe Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 489. MEA Plant-based Vaccines Sales, by Country K Tons (2023-2028)
  • Table 490. MEA Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 491. MEA Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 492. MEA Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 493. MEA Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 494. Middle East Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 495. Middle East Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 496. Middle East Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 497. Middle East Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 498. Africa Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 499. Africa Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 500. Africa Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 501. Africa Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 502. North America Plant-based Vaccines Sales, by Country K Tons (2023-2028)
  • Table 503. North America Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 504. North America Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 505. North America Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 506. North America Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 507. United States Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 508. United States Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 509. United States Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 510. United States Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 511. Canada Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 512. Canada Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 513. Canada Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 514. Canada Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 515. Mexico Plant-based Vaccines Sales, by Type K Tons (2023-2028)
  • Table 516. Mexico Plant-based Vaccines Sales, by Application K Tons (2023-2028)
  • Table 517. Mexico Plant-based Vaccines Sales, by Plant K Tons (2023-2028)
  • Table 518. Mexico Plant-based Vaccines Sales, by End Users K Tons (2023-2028)
  • Table 519. Plant-based Vaccines: by Type(USD/Units)
  • Table 520. Research Programs/Design for This Report
  • Table 521. Key Data Information from Secondary Sources
  • Table 522. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Plant-based Vaccines: by Type USD Million (2017-2022)
  • Figure 5. Global Plant-based Vaccines: by Application USD Million (2017-2022)
  • Figure 6. Global Plant-based Vaccines: by Plant USD Million (2017-2022)
  • Figure 7. Global Plant-based Vaccines: by End Users USD Million (2017-2022)
  • Figure 8. South America Plant-based Vaccines Share (%), by Country
  • Figure 9. Asia Pacific Plant-based Vaccines Share (%), by Country
  • Figure 10. Europe Plant-based Vaccines Share (%), by Country
  • Figure 11. MEA Plant-based Vaccines Share (%), by Country
  • Figure 12. North America Plant-based Vaccines Share (%), by Country
  • Figure 13. Global Plant-based Vaccines: by Type K Tons (2017-2022)
  • Figure 14. Global Plant-based Vaccines: by Application K Tons (2017-2022)
  • Figure 15. Global Plant-based Vaccines: by Plant K Tons (2017-2022)
  • Figure 16. Global Plant-based Vaccines: by End Users K Tons (2017-2022)
  • Figure 17. South America Plant-based Vaccines Share (%), by Country
  • Figure 18. Asia Pacific Plant-based Vaccines Share (%), by Country
  • Figure 19. Europe Plant-based Vaccines Share (%), by Country
  • Figure 20. MEA Plant-based Vaccines Share (%), by Country
  • Figure 21. North America Plant-based Vaccines Share (%), by Country
  • Figure 22. Global Plant-based Vaccines: by Type USD/Units (2017-2022)
  • Figure 23. Global Plant-based Vaccines share by Players 2022 (%)
  • Figure 24. Global Plant-based Vaccines share by Players (Top 3) 2022(%)
  • Figure 25. Global Plant-based Vaccines share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Medicago (Canada) Revenue, Net Income and Gross profit
  • Figure 28. Medicago (Canada) Revenue: by Geography 2022
  • Figure 29. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2022
  • Figure 31. Creative Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 32. Creative Biolabs (United States) Revenue: by Geography 2022
  • Figure 33. IBio (United States) Revenue, Net Income and Gross profit
  • Figure 34. IBio (United States) Revenue: by Geography 2022
  • Figure 35. Fraunhofer (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Fraunhofer (Germany) Revenue: by Geography 2022
  • Figure 37. ICON (Ireland) Revenue, Net Income and Gross profit
  • Figure 38. ICON (Ireland) Revenue: by Geography 2022
  • Figure 39. Mitsubishi Tanabe (Japan) Revenue, Net Income and Gross profit
  • Figure 40. Mitsubishi Tanabe (Japan) Revenue: by Geography 2022
  • Figure 41. Protalix (Israel) Revenue, Net Income and Gross profit
  • Figure 42. Protalix (Israel) Revenue: by Geography 2022
  • Figure 43. Kentucky Bioprocessing, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Kentucky Bioprocessing, Inc. (United States) Revenue: by Geography 2022
  • Figure 45. Global Plant-based Vaccines: by Type USD Million (2023-2028)
  • Figure 46. Global Plant-based Vaccines: by Application USD Million (2023-2028)
  • Figure 47. Global Plant-based Vaccines: by Plant USD Million (2023-2028)
  • Figure 48. Global Plant-based Vaccines: by End Users USD Million (2023-2028)
  • Figure 49. South America Plant-based Vaccines Share (%), by Country
  • Figure 50. Asia Pacific Plant-based Vaccines Share (%), by Country
  • Figure 51. Europe Plant-based Vaccines Share (%), by Country
  • Figure 52. MEA Plant-based Vaccines Share (%), by Country
  • Figure 53. North America Plant-based Vaccines Share (%), by Country
  • Figure 54. Global Plant-based Vaccines: by Type K Tons (2023-2028)
  • Figure 55. Global Plant-based Vaccines: by Application K Tons (2023-2028)
  • Figure 56. Global Plant-based Vaccines: by Plant K Tons (2023-2028)
  • Figure 57. Global Plant-based Vaccines: by End Users K Tons (2023-2028)
  • Figure 58. South America Plant-based Vaccines Share (%), by Country
  • Figure 59. Asia Pacific Plant-based Vaccines Share (%), by Country
  • Figure 60. Europe Plant-based Vaccines Share (%), by Country
  • Figure 61. MEA Plant-based Vaccines Share (%), by Country
  • Figure 62. North America Plant-based Vaccines Share (%), by Country
  • Figure 63. Global Plant-based Vaccines: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Medicago (Canada)
  • GlaxoSmithKline (United Kingdom)
  • Creative Biolabs (United States)
  • iBio (United States)
  • Fraunhofer (Germany)
  • ICON (Ireland)
  • Mitsubishi Tanabe (Japan)
  • Protalix (Israel)
  • Kentucky Bioprocessing, Inc. (United States)
Additional players considered in the study are as follows:
Proeon (India) , Mammoth Biosciences (United States) , Inscripta Therapeutics (United States)
Select User Access Type

Key Highlights of Report


Oct 2023 225 Pages 57 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Plant-based Vaccines Market Quantitative research analysis
Global Plant-based Vaccines Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Plant-based Vaccines Market are Medicago (Canada), GlaxoSmithKline (United Kingdom), Creative Biolabs (United States), iBio (United States), Fraunhofer (Germany), ICON (Ireland), Mitsubishi Tanabe (Japan), Protalix (Israel) and Kentucky Bioprocessing, Inc. (United States) etc.
Infectious Diseases segment in Global market to hold robust market share owing to "Plant-Based Vaccines are Produced on a Large Scale and are Cost-Effective ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Plant-based Vaccines market throughout the forecasted period.

Know More About Global Plant-based Vaccines Market Report?

Have a Query? Click Here

Other Related Reports

Bioprocessing Bags Comprehensive Study by Type (D Bags, 3D Bags, Wave / Rocker Bags, Single Use Mixing System, Filter Bag System), End Users (Bioprocessing Laboratories, Hospitals, Biopharmaceutical ...
$ 3750
Triglycerides Testing Reagents Comprehensive Study by Application (Hospitals, Specialty Clinics, Diagnostic Centers), Triglyceride Causes (Lack Of Exercise, Being Overweight, Smoking Cigarettes, Con...
$ 3450
Cannabinoid Biosynthesis Comprehensive Study by Application (Epilepsy, Cancer Chemotherapy, Nausea and Vomiting, Appetite Stimulation, Other), Drug (Cannabidiol, Tetrahydrocannabinol, Cannabigerol, T...
$ 3750
Airlift Bioreactors Comprehensive Study by Type (Internal Airlift Loop Bioreactor, External Airlift Loop Bioreactor), Usage (Disposal, Reusable), Capacity (5L, 7L, 10L, 30L), Material (Stainless Stee...
$ 3450
Osteoarthritis Gene Therapy Comprehensive Study by Type (Synovium Injection, Cartilage Injection), Vectors (Non-viral, Retrovirus, Lentivirus, Adenovirus, Adeno-associated virus (AAV), HSV), End User...
$ 3800
Virology Comprehensive Study by Application (Medicine, Agriculture, Nanotechnology, Others), Diagnosis Test (Hepatitis B, Hepatitis C, HIV, Other), Disease (AIDS, Common Cold, Ebola, Genital Herpes, ...
$ 3500